Parallel imaging aids 3D MRA in infants
Parallel imaging has reduced acquisition time for contrast MR, making it possible to use 3D MR angiography in imaging infants with suspected congenital abnormalities.
Parallel imaging has reduced acquisition time for contrast MR, making it possible to use 3D MR angiography in imaging infants with suspected congenital abnormalities.
The new capability was demonstrated in a study of 22 infants and small children at the University of Heidelberg using time-resolved 3D FLASH MRA performed with GRAPPA using an acceleration factor of 2 on a 1.5T scanner. All studies were deemed diagnostic with no relevant motion artifacts, according to Dr. Joachim Eichorn. Small aberrant vessels including multiple aortopulmonary collateral arteries were visualized.
In related research, Dr. Jochem van den Berg at Sophia Children's Hospital in Rotterdam, the Netherlands, found perfusion imaging uncovers otherwise undetected ventricular diastolic dysfunctions including impaired relaxation and filling restrictions linked to the tetralogy of Fallot.
Dr. Giulia Russo at the University of Padua in Padova, Italy, described the value of delayed-enhancement MRI for assessing the risk of sudden death among 27 consecutive adults with repaired tetralogy of Fallot. Delayed enhancement was seen in seven of eight patients with histories of life-threatening arrhythmic events but only two of 19 without incidences of sustained ventricular tachycardia.
This special section was compiled by James Brice, senior editor of Diagnostic Imaging.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
